Metacrine, Inc.·4

Sep 22, 5:01 PM ET

Millican Trisha 4

4 · Metacrine, Inc. · Filed Sep 22, 2020

Insider Transaction Report

Form 4
Period: 2020-09-18
Millican Trisha
Chief Financial Officer
Transactions
  • Conversion

    Common Stock

    2020-09-18+9,80367,248 total(indirect: See footnote)
  • Conversion

    Series A Convertible Preferred Stock

    2020-09-189,8030 total(indirect: See footnote)
    Common Stock (9,803 underlying)
Holdings
  • Common Stock

    41,033
Footnotes (2)
  • [F1]Every 5.1 shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (the "Preferred Stock") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
  • [F2]Millican Family Trust, dated March 10, 2016

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION